On the recordMay 8, 2019
it is my hope that we might consider Federal legislation regarding transparency.
Source
congress.govEditor's note · Context
Eshoo advocates for potential federal legislation to enhance transparency in drug pricing.
Share
More from Anna Eshoo
Dec 11, 2023
I thank the ranking member of the full committee for yielding time. Today, the House is going to vote on my legislation, H.R. 3226, the PREEMIE Reauthorization Act. I thank the co-leads of this legislation: Representatives Miller-Meeks…
May 22, 2023
I've long been a champion for protecting vulnerable communities from the harms that come with new technologies.
Jun 20, 2023
It is stunning to me that someone pays for something, they don't get it, but the person or the entity they paid it to still gets to keep it.
Apr 17, 2023
I urge the Committee to include language in FAA reauthorization that mirrors what was in a previous bill.
Other voices in this conversation
